We are live on
!
Find out more
YF
Yu Fan Portfolio holdings
AUM
$97M
1-Year Est. Return
57.2%
This Fund
S&P 500
This Quarter
Est. Return
-6.01%
1 Year Est. Return
+57.2%
3 Year Est. Return
-14.37%
5 Year Est. Return
-61.92%
10 Year Est. Return
–
AUM
$72.5M
AUM Growth
+$52.6M
(+264%)
Cap. Flow
+$8.39M
Cap. Flow
% of AUM
11.56%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
3
Increased
–
Reduced
–
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spyre Therapeutics
SYRE
|
+$21.4M |
| 2 |
Prenetics Global
PRE
|
+$6.05M |
| 3 |
SONX
Sonendo, Inc.
SONX
|
+$498K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRGX
CARGO Therapeutics
CRGX
|
+$19M |
| 2 |
Castle Biosciences
CSTL
|
+$486K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 75.8% |
| 2 | Healthcare | 24.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Prenetics Global
PRE
$323M
| $55M | 75.8% |
+1,252,438
| New | +$6.05M |
|
|
2
Spyre Therapeutics
SYRE
$8.83B
| $16.4M | 22.68% |
+737,000
| New | +$21.4M |
|
|
SONX
3
DELISTED
Sonendo, Inc.
SONX
| $498K | 0.69% |
+22,503
| New | +$498K |
|
4
Sagimet Biosciences
SGMT
$430M
| $310K | 0.43% |
57,190
| – | – |
|
5
Pyxis Oncology
PYXS
$171M
| $295K | 0.41% |
69,303
| – | – |
|
|
CRGX
6
DELISTED
CARGO Therapeutics
CRGX
| – | – |
-822,171
| Closed | -$19M |
|
|
7
Castle Biosciences
CSTL
$761M
| – | – |
-22,503
| Closed | -$486K |
|
Similar funds
ACM
AWP
SFO
CSW
TFS
FA
JKSF
BFA
Yu Fan's Q1 2024 Portfolio in Review
As of Q1 2024, Yu Fan held 7 positions worth $72.5M, up 264% from $20M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Yu Fan deployed $8.39M of net new capital in Q1 2024, opening 3 new positions. Its largest new stake was Spyre Therapeutics: 737,000 shares worth $16.4M.
By sector, the portfolio is most concentrated in Consumer Staples at 76% of assets, up from 0% a quarter earlier, followed by Healthcare.
On the sell side, the most notable exit was CARGO Therapeutics, an estimated $19M sold.
- Yu Fan's largest Q1 2024 buy was Spyre Therapeutics: 737,000 shares worth $16.4M.
- Yu Fan fully exited CARGO Therapeutics in Q1 2024, selling an estimated $19M.
- Yu Fan's ten largest holdings make up 100% of its $72.5M portfolio in Q1 2024.
- Yu Fan opened 3 new positions and closed 2 in Q1 2024.
- Yu Fan's portfolio value rose 264% quarter-over-quarter to $72.5M.
Based on Yu Fan's 13F filing for Q1 2024, filed 15 May 2024.